Qin Shan, Tao Yexiao, Tang Chenzhe, Zhang Qi, Li Yong, Fei Zhengdong
Department of Cardiology, the First People's Hospital of Yuhang District, Hangzhou, Zhejiang, 311100, China.
Department of Cardiology, Suining County People's Hospital, Xuzhou, Jiangsu, 221200, China.
BMC Cardiovasc Disord. 2025 Jul 16;25(1):516. doi: 10.1186/s12872-025-04989-x.
The HATCH score, a new atrial fibrillation (AF) risk model, has drawn wide attention. However, in patients with ST-segment elevation myocardial infarction (STEMI), the relationship between the HATCH score and NOAF remains unclear. This study aimed to assess the association between HATCH score and new-onset AF (NOAF) after percutaneous coronary intervention (PCI) in STEMI patients.
This single-center retrospective observation consecutively selected patients diagnosed with STEMI who underwent primary PCI. All patients received continuous electrocardiogram monitoring during hospitalization (≥ 36 h). HATCH score was calculated based on hypertension (1 point), age > 75 years (1 point), stroke or TIA (2 point), COPD (1 point), and HF (2 point).
A total of 774 patients were included in this study, of whom 65.37% were male, with a mean age of 63.53 ± 13.11 years, 73 patients (9.43%) developed NOAF. ROC curve demonstrated that the AUC of the HATCH score was 0.731, the cut - off value was 2.5. Multivariate logistic regression analysis indicated that the HATCH score (OR = 1.66, 95% CI: 1.41-1.95, P < 0.001) or HATCH score ≥ 3 (OR = 4.10, 95% CI: 2.39-7.02, P < 0.001) was an independent risk predictor for NOAF. The RCS analysis revealed a linear correlation between the HATCH score and NOAF (P for overall < 0.001).
Elevated HATCH score is an independent risk factor for the development of NOAF after PCI in STEMI patients. There was a linear dose-response relationship between HATCH score and NOAF.
HATCH评分作为一种新的房颤（AF）风险模型，已引起广泛关注。然而，在ST段抬高型心肌梗死（STEMI）患者中，HATCH评分与非房颤（NOAF）之间的关系仍不清楚。本研究旨在评估STEMI患者经皮冠状动脉介入治疗（PCI）后HATCH评分与新发房颤（NOAF）之间的关联。
本单中心回顾性观察连续选取诊断为STEMI并接受直接PCI的患者。所有患者在住院期间（≥36小时）接受持续心电图监测。HATCH评分基于高血压（1分）、年龄>75岁（1分）、中风或短暂性脑缺血发作（2分）、慢性阻塞性肺疾病（1分）和心力衰竭（2分）进行计算。
本研究共纳入774例患者，其中65.37%为男性，平均年龄为63.53±13.11岁，73例（9.43%）发生NOAF。ROC曲线显示，HATCH评分的AUC为0.731，临界值为2.5。多因素logistic回归分析表明，HATCH评分（OR=1.66，95%CI：1.41-1.95，P<0.001）或HATCH评分≥3（OR=4.10，95%CI：2.39-7.02，P<0.001）是NOAF的独立风险预测因素。RCS分析显示HATCH评分与NOAF之间存在线性相关性（总体P<0.001）。
HATCH评分升高是STEMI患者PCI后发生NOAF的独立危险因素。HATCH评分与NOAF之间存在线性剂量反应关系。
